A Farnesyl-Protein Transferase Inhibitor Induces p21 Expression and G1 Block in p53 Wild Type Tumor Cells

作者: Laura Sepp-Lorenzino , Neal Rosen

DOI: 10.1074/JBC.273.32.20243

关键词:

摘要: Farnesylation is required for the membrane partition and function of several proteins, including Ras. Farnesyl-protein transferase inhibitors (FTIs) were developed to prevent Ras processing thus be effective agents treatment cancers harboring mutated ras. However, FTIs inhibit growth most tumor cells xenograft models, irrespective whether they possess Furthermore, antiproliferative effect not correlated with inhibition Ki-Ras processing; tumors wild type rasare inhibited, are particularly toxic. These data suggest that mechanism FTI action complex may involve other targets besides To begin understand how work, we investigated inhibition. causes G1 arrest in a subset sensitive lines. This accomplished by transcriptional induction p21, which mediates cyclin E-associated protein kinase activity, pRb hypophosphorylation DNA replication. Induction p21 p53-dependent; it does occur mutant p53 or expressing human papillomavirus E6. neither nor cell proliferation. still blocks deficient these proteins. In absence block relaxed, replication affected, become polyploid undergo apoptosis. results farnesylated protein(s) involved regulating coordinating entrance into S, consequences mutations found cell.

参考文章(44)
Andrew D. Hamilton, Jiazhi Sun, Karine Miquel, Yimin Qian, Anne Pradines, Gilles Favre, Saïd M. Sebti, GGTI-298 Induces G0-G1 Block and Apoptosis Whereas FTI-277 Causes G2-M Enrichment in A549 Cells Cancer Research. ,vol. 57, pp. 1846- 1850 ,(1997)
Bert Vogelstein, Kenneth W. Kinzler, Todd Waldman, p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Research. ,vol. 55, pp. 5187- 5190 ,(1995)
Elaine Rands, Allen Oliff, Nancy E. Kohl, Neal Rosen, Jackson B. Gibbs, Laura Sepp-Lorenzino, Zhenping Ma, A Peptidomimetic Inhibitor of Farnesyl:Protein Transferase Blocks the Anchorage-dependent and -independent Growth of Human Tumor Cell Lines Cancer Research. ,vol. 55, pp. 5302- 5309 ,(1995)
Peter M. Howley, Carl G. Maki, Jon M. Huibregtse, In Vivo Ubiquitination and Proteasome-mediated Degradation of p53 Cancer Research. ,vol. 56, pp. 2649- 2654 ,(1996)
D.P. Lane, B. Vojtesek, Regulation of p53 protein expression in human breast cancer cell lines. Journal of Cell Science. ,vol. 105, pp. 607- 612 ,(1993)
Nancy E. Kohl, Charles A. Omer, Michael W. Conner, Neville J. Anthony, Joseph P. Davide, S. Jane Desolms, Elizabeth A. Giuliani, Robert P. Gomez, Samuel L. Graham, Kelly Hamilton, Laurence K. Handt, George D. Hartman, Kenneth S. Koblan, Astrid M. Kral, Patricia J. Miller, Scott D. Mosser, Timothy J. O'Neill, Elaine Rands, Michael D. Schaber, Jackson B. Gibbs, Allen Oliff, Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice Nature Medicine. ,vol. 1, pp. 792- 797 ,(1995) , 10.1038/NM0895-792
Andreas Vogt, Jiazhi Sun, Yimin Qian, Andrew D. Hamilton, Saı̈d M. Sebti, The Geranylgeranyltransferase-I Inhibitor GGTI-298 Arrests Human Tumor Cells in G0/G1 and Induces p21WAF1/CIP1/SDI1 in a p53-independent Manner * Journal of Biological Chemistry. ,vol. 272, pp. 27224- 27229 ,(1997) , 10.1074/JBC.272.43.27224
Jaekyung Shim, Heejeong Lee, Jihyun Park, Hanshin Kim, Eui-Ju Choi, A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature. ,vol. 381, pp. 804- 807 ,(1996) , 10.1038/381804A0
Cheryl A. Rowell, James J. Kowalczyk, Michael D. Lewis, Ana Maria Garcia, Direct Demonstration of Geranylgeranylation and Farnesylation of Ki-Ras in Vivo Journal of Biological Chemistry. ,vol. 272, pp. 14093- 14097 ,(1997) , 10.1074/JBC.272.22.14093
Michael Nüsse, Wolfgang Beisker, Christine Hoffmann, Attila Tarnok, Flow cytometric analysis of G1‐ and G2/M‐phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements Cytometry. ,vol. 11, pp. 813- 821 ,(1990) , 10.1002/CYTO.990110707